WELCURE DRUG | BLUE PEARL TEXSPIN | WELCURE DRUG/ BLUE PEARL TEXSPIN |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 540.5 | 566.1 | 95.5% | View Chart |
P/BV | x | 3.9 | - | - | View Chart |
Dividend Yield | % | 0.0 | 0.0 | - |
WELCURE DRUG BLUE PEARL TEXSPIN |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
WELCURE DRUG Mar-23 |
BLUE PEARL TEXSPIN Mar-23 |
WELCURE DRUG/ BLUE PEARL TEXSPIN |
5-Yr Chart Click to enlarge
|
||
High | Rs | 12 | 36 | 32.5% | |
Low | Rs | 4 | 25 | 14.2% | |
Sales per share (Unadj.) | Rs | 0 | 8.6 | 0.0% | |
Earnings per share (Unadj.) | Rs | 0.1 | -0.3 | -28.0% | |
Cash flow per share (Unadj.) | Rs | 0.1 | -0.3 | -28.9% | |
Dividends per share (Unadj.) | Rs | 0 | 0 | - | |
Avg Dividend yield | % | 0 | 0 | - | |
Book value per share (Unadj.) | Rs | 1.1 | -4.5 | -25.1% | |
Shares outstanding (eoy) | m | 13.51 | 0.26 | 5,196.2% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0 | 3.5 | - | |
Avg P/E ratio | x | 100.7 | -107.6 | -93.5% | |
P/CF ratio (eoy) | x | 97.5 | -107.6 | -90.6% | |
Price / Book Value ratio | x | 6.8 | -6.7 | -100.7% | |
Dividend payout | % | 0 | 0 | - | |
Avg Mkt Cap | Rs m | 102 | 8 | 1,312.7% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 0 | 0 | 165.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 0 | 2 | 0.0% | |
Other income | Rs m | 2 | 0 | - | |
Total revenues | Rs m | 2 | 2 | 106.3% | |
Gross profit | Rs m | -1 | 0 | 1,885.7% | |
Depreciation | Rs m | 0 | 0 | - | |
Interest | Rs m | 0 | 0 | - | |
Profit before tax | Rs m | 1 | 0 | -1,457.1% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 0 | 0 | - | |
Profit after tax | Rs m | 1 | 0 | -1,457.1% | |
Gross profit margin | % | 0 | -3.2 | - | |
Effective tax rate | % | 0 | 0 | - | |
Net profit margin | % | 0 | -3.2 | - |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 0 | 2 | 3.5% | |
Current liabilities | Rs m | 0 | 3 | 4.5% | |
Net working cap to sales | % | 0 | -62.4 | - | |
Current ratio | x | 0.4 | 0.6 | 77.5% | |
Inventory Days | Days | 0 | 35 | - | |
Debtors Days | Days | 0 | 1,348,184 | - | |
Net fixed assets | Rs m | 15 | 0 | 6,621.7% | |
Share capital | Rs m | 134 | 3 | 5,249.6% | |
"Free" reserves | Rs m | -119 | -4 | 3,205.4% | |
Net worth | Rs m | 15 | -1 | -1,306.0% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 15 | 2 | 788.1% | |
Interest coverage | x | 0 | 0 | - | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 0 | 1.1 | 0.0% | |
Return on assets | % | 6.7 | -3.7 | -180.5% | |
Return on equity | % | 6.7 | 6.2 | 108.5% | |
Return on capital | % | 6.7 | 6.2 | 108.9% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 0 | - | |
Fx outflow | Rs m | 0 | 0 | - | |
Net fx | Rs m | 0 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1 | 0 | -232.6% | |
From Investments | Rs m | 13 | NA | - | |
From Financial Activity | Rs m | -15 | 1 | -2,984.0% | |
Net Cashflow | Rs m | -1 | 0 | -1,625.0% |
Indian Promoters | % | 0.0 | 0.1 | - | |
Foreign collaborators | % | 0.0 | 19.5 | - | |
Indian inst/Mut Fund | % | 0.0 | 0.0 | - | |
FIIs | % | 0.0 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 100.0 | 80.3 | 124.5% | |
Shareholders | 31,530 | 8,401 | 375.3% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare WELCURE DRUG With: ADANI ENTERPRISES REDINGTON MMTC SIRCA PAINTS INDIA TVS ELECTRON
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | WELCURE DRUG | E-WHA FOAM (I) | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -4.97% | 0.00% | -0.44% |
1-Month | 11.68% | 0.00% | -0.19% |
1-Year | 8.91% | 19.44% | 53.63% |
3-Year CAGR | 27.96% | 51.78% | 14.59% |
5-Year CAGR | 57.09% | 28.37% | 19.77% |
* Compound Annual Growth Rate
Here are more details on the WELCURE DRUG share price and the E-WHA FOAM (I) share price.
Moving on to shareholding structures...
The promoters of WELCURE DRUG hold a 0.0% stake in the company. In case of E-WHA FOAM (I) the stake stands at 19.7%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of WELCURE DRUG and the shareholding pattern of E-WHA FOAM (I).
Finally, a word on dividends...
In the most recent financial year, WELCURE DRUG paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
E-WHA FOAM (I) paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of WELCURE DRUG, and the dividend history of E-WHA FOAM (I).
For a sector overview, read our pharmaceuticals sector report.
After opening the day on positive note, Indian share markets reversed the trend as the session progressed and ended lower.